Bal Pharma Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Bal Pharma Limited Company Profile :

Bal Pharma Limited is an Indian company engaged in the business of manufacture and sale of pharmaceutical products. The Company’s business comprises of Active Pharmaceutical Ingredients (API), Finished Formulations, Ayurvedic, Research and Development. It is in prescription drugs, generics, over-the-counter (OTC) products, intravenous infusion and bulk actives.


Bal Pharma Limited ResultsBSE Code : 524824
NSE Symbol : BALPHARMA
ISIN No. : INE083D01012
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Bal Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Bal Pharma.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Bal Pharma. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Bal Pharma.

Bal Pharma Q1 Results 2016-17 :

Bal Pharma will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Bal Pharma will announce its Q2 FY 2016-17 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Bal Pharma will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Bal Pharma will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Bal Pharma will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Bal Pharma Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 197.66 198.31
Other Income 1.50  1.28
Total Income 199.15  199.59
Expenditure -180.52 -190.47
Interest -6.48 -6.47
Depreciation -6.97  -7.00
PBT  5.18 2.65
Tax  -2.38  -2.39
Net Profit  2.81  0.25
Equity  12.87  12.87
EPS 2.18  1.73

Note : If you like this information about Bal Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.